Melanoma Institute Australia celebrates International Women's Day
8 March 2017
To celebrate International Women's Day, we're sharing how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.
Meet Danielle Fischer, our Science Communications Specialist.
"I wanted my career to make a difference to people, and I always had a passion for science, so studying Medical Science at uni was the obvious choice. After a few years working in the lab, I decided I enjoyed talking about research rather than actually doing it! And so by accident, I stumbled into Science Communications – a field I never knew existed while studying. It’s the perfect mix for me and I enjoy translating complex medical research for the general public to appreciate. I particularly like translating research that gives hope to patients."
This is Tuba Nur Gide, PhD student and winner of NSW National Council of Women Australia Day Award for her research focused on the role of immunotherapies in melanoma.
"My parents raised me to work hard, be independent and do well academically – they value education very highly. I think that’s why even as a little girl, I knew that I wanted to pursue completing a PhD, in whatever field of study I would end up choosing.
Having been awarded a PhD Scholarship from MIA two years in a row now is an opportunity that I am truly humbled by. Knowing people close to me that have been affected by cancer drives me even further to do the very best that I can.
I believe that it’s really important for females to have equal opportunity. All women should be valued as individuals. We’re strong, we’re smart and no one should push us around. Careers shouldn’t be defined by your gender and I hope that in the future, education opportunities offered to young boys and girls are free of gender bias or sexism.”
Maria Gonzalez, Clinical Trials Manager here at MIA.
"I completed an undergraduate degree in nursing at The University of Sydney and further postgraduate studies in health science. I am fortunate to have accessed training and education which has enabled me to pursue a career combining both cancer care and clinical research.
Women make up about 90% of Australia’s nursing workforce and play a pivotal role in clinical care and research. Today I will be bold and celebrate the valuable contribution and achievements of all nurses in the fight against cancer."
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.